Home » Topics » Regulatory » Patents

Patents
RSS

Leukotriene biosynthesis inhibitors from Abbott

May 21, 1997

Excitatory amino acid antagonists disclosed by Glaxo Wellcome

May 21, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Fujisawa describes new cephems

May 21, 1997

MMP/TNF/CD23 inhibitors prepared by Chiroscience

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

HIV-1 RT inhibitors from Boehringer Ingelheim

May 20, 1997

Searle describes antiplatelet agents

May 20, 1997

ADIR discloses compounds with high affinity for human D3 receptors

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...